3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
2
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
2
Conditions
Breast Neoplasms
360
Neoplasms
255
Carcinoma, Non-Small-Cell Lung
199
Colorectal Neoplasms
183
Lung Neoplasms
152
Prostatic Neoplasms
151
Carcinoma, Hepatocellular
128
Leukemia, Myeloid, Acute
96
Pancreatic Neoplasms
86
Multiple Myeloma
84
Neoplasm Metastasis
74
Recurrence
71
Uterine Cervical Neoplasms
69
Rectal Neoplasms
68
Stomach Neoplasms
65
Ovarian Neoplasms
65
Triple Negative Breast Neoplasms
60
Squamous Cell Carcinoma of Head and Neck
57
Head and Neck Neoplasms
54
Glioblastoma
54
Brain Neoplasms
54
Precursor Cell Lymphoblastic Leukemia-Lymphoma
51
Small Cell Lung Carcinoma
50
Endometrial Neoplasms
47
Melanoma
44
Esophageal Neoplasms
43
Disease
43
Colonic Neoplasms
42
Hematologic Neoplasms
41
Glioma
40
Interventions
pembrolizumab
1
enfortumab vedotin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Advanced Bladder Cancer
×
1 year
×
Clear all
NCT07346053
2026-01-16
Chrono-EVP
British Columbia Cancer Agency
Phase 3
Not yet recruiting
224 enrolled
NCT07204496
2025-10-02
γδ-T-BLADDER
Shanghai 10th People's Hospital
Not yet recruiting
20 enrolled